323114 VU The path from bench to bedside - a regulatory view - MPS5 (2024S)
Continuous assessment of course work
Labels
Anmeldung jederzeit möglich bis 21.04.2024 12.00 Uhr
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Tu 30.01.2024 10:00 to Su 21.04.2024 12:00
- Deregistration possible until Su 21.04.2024 12:00
Details
Information
Aims, contents and method of the course
Assessment and permitted materials
1. Attendance & Participation: participants are expected to attend all course sessions and actively participate in the course.
2. Oral presentations and written exercises to be handed in as outlined during the course.
2. Oral presentations and written exercises to be handed in as outlined during the course.
Minimum requirements and assessment criteria
1. Class attendance
2. Active participation in class and with team.
3. Written short IB or IMPD for a pharmaceutical drug.
4. Presentation of the IB or IMPDs
2. Active participation in class and with team.
3. Written short IB or IMPD for a pharmaceutical drug.
4. Presentation of the IB or IMPDs
Examination topics
Reading list
Association in the course directory
Last modified: Th 01.02.2024 15:26
Based on the acquired knowledge a short IMPD will be prepared for a pharmaceutical drug. The IMPDs will be rated in a peer-reviewed process by the students. Finally, the revised IMPD will be presented in the auditorium.The lecture will be in english and in an online setting
Enrollment possible untill 19.04.2024Dates:
6. May 4-5:30 pm
13. May 4-4:45 pm
27. May 4-4:45 pm
3. June 4-4:45 pm
10. June 4-4:45 pm
17. June 4-4:45 pm